Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,763 shares at $459.83 ($1.3M) on 2025-02-11, disclosed to the SEC on 2025-02-12.
Scheduled sale ($1.3M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $467.98 | 2,143 | $1.0M | 77.9% |
| 2 | $459.83 | 310 | $143K | 11.1% |
| 3 | $459.83 | 310 | $143K | 11.1% |
| Total | $466.15 avg | 2,763 | $1.3M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |